Skip to main content
Y.S.H. logo

Y.S.H. — Investor Relations & Filings

Ticker · 3705 ISIN · TW0003705000 TW Financial and insurance activities
Open in API
Filings indexed 2,126 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country TW Taiwan
Listing TW 3705

About Y.S.H.

www.yungshingroup.com

YungShin Global Holding Corporation is an investment holding company focused on the pharmaceutical and comprehensive healthcare sectors. Through its subsidiaries, the group manages an integrated value chain that spans research and development, manufacturing, and global distribution. Its diverse product portfolio includes human prescription and over-the-counter generic medicines, active pharmaceutical ingredients (APIs), animal health products, and health supplements. The company also provides cosmetics and specialty chemicals. Leveraging advanced enterprise resource planning systems to ensure operational transparency and quality control, the group serves a broad international market. Its core mission centers on delivering holistic health solutions and maintaining a robust presence across the healthcare supply chain, supported by a long-standing commitment to social welfare and community health initiatives.

Recent filings

Filing Released Lang Actions
115年05月僑外投資持股
Regulatory Filings Classification · 80% confidence The document is a compliance filing from Taiwan’s Public Information Observatory showing aggregated shareholding statistics for overseas Chinese, foreign, and Mainland investors. It is not announcing dividends, earnings, management changes, or any specific financial report, nor does it detail a major shareholder crossing a threshold by name. Instead it is a routine regulatory disclosure of shareholding composition. Therefore it falls under the general “Regulatory Filings” category (RNS).
2026-05-11 Chinese
115年04月內部人持股異動(事後)
Regulatory Filings Classification · 100% confidence The document text indicates an error message stating that the page cannot be accessed due to security reasons. There is no financial, regulatory, or corporate information present. The content is essentially a website error notice with no report or announcement content. Therefore, it does not fit any specific filing category and should be classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2026-05-05 Chinese
115年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors and senior management. It provides specific data on share counts, pledged shares, and relationships of insiders. The content focuses on insider shareholdings and pledging status rather than financial results, management changes, or meeting materials. This type of disclosure aligns with reporting of personal share transactions or holdings by company directors and executives. Therefore, the document fits best under the category of Director's Dealing (DIRS). The document length is relatively short and does not indicate it is an announcement or a report publication notice, so it is not RPA or RNS. Confidence is high given the clear insider shareholding data presented.
2026-05-05 Chinese
代重要子公司永信藥品工業(股)公司公告 114年度現金股利配發基準日
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from a company regarding the cash dividend distribution details for the fiscal year 114. It includes specific dates related to dividend payment, ex-dividend date, record date, and other dividend-related information. There is no financial statement or detailed report content, only dividend payment information. This matches the definition of a Notice of Dividend Amount (DIV). The document length is short and focused solely on dividend details, confirming it is not a full report or earnings release but a dividend announcement.
2026-05-05 Chinese
代重要子公司永信藥品工業股份有限公司公告董事會 重要決議事項
Board/Management Information Classification · 95% confidence The document is a regulatory announcement from a listed company (3705 永信) reporting important resolutions passed by the board of directors of a significant subsidiary. The content includes approval of the subsidiary's annual business report, financial statements, profit distribution, and remuneration for executives. The document is short (796 characters) and serves as a notification of board decisions rather than the full annual report or financial statements themselves. It does not contain detailed financial data or comprehensive report content. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or important decisions by the board or senior management.
2026-05-05 Chinese
公告本公司115年度第一季財務報告 董事會預計召開日期為115年05月06日
Report Publication Announcement Classification · 80% confidence The document is a brief TWSE disclosure announcing the board meeting date (May 6) to approve the company’s 115th year first quarter financial report. It does not contain the actual financial statements but merely notifies the upcoming report publication. According to the “menu vs meal” rule, this is a Report Publication Announcement.
2026-04-28 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.